Biological drug therapies
Biological therapies for cancer are often referred to as targeted therapies. They involve either chemicals or modified antibodies that act on one or several target molecules in cancer cells.
A typical example of biological cancer therapy is an antibody that binds with target molecules present on the surface of HER2-positive breast cancer cells and inhibits signal transduction, thus slowing down cancer progression. Biological therapies are currently subject to intensive research and development by the pharmaceutical industry.
For some cancers, research has already resulted in the development of highly targeted therapies with the desired action and effect. However, many of the new agents have improved treatment results only slightly as compared to conventional cancer chemotherapy.
Docrates Cancer Center celebrates its 15th anniversary – one step ahead of cancer
24.11.2022 | The private cancer hospital Docrates Cancer Center is celebrating its 15th anniversary this year. Docrates Cancer Center is...Read more
Study: How cancer affects your sex life – “It’s good to remember that sexuality is not the same as intercourse,” says Professor Timo Joensuu
Oct 19, 2022 | Cancer can be difficult both physically and mentally. It can have a major impact on your...Read more
Breakthroughs in the treatment of metastatic breast cancer
New forms of drug therapy can almost double the life expectancy of patients with advanced breast cancer and allow treatment...Read more
Docrates Cancer Center has appointed Anna-Sofia Malmi as Marketing and Communications Director
Anna-Sofia Malmi, M.Sc (Education), has been appointed as Marketing and Communications Director at Docrates Cancer Center and a member of...Read more
Why come to Docrates Cancer Center?
- Top cancer experts and effective treatments without delay.
- Individual care. You have your own care team - your doctor and your nurse.
- Front line cancer treatment. Latest medical technology combined with proven expertise in cancer care.
- Experience in treating international patients from over 60 countries. Multilingual personnel.